Outcomes4me Inc.
A patient navigation platform that creates integrated survivorship care plans, coordinates care, and facilitates communication between cancer survivors and healthcare providers
- Sector
- Digital health
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2017
- Latest Form D
- $12M, Apr 2021
- Total capital
- $16.9M
- Federal grants
- $400K
- 1 award
- Sector median 0 awards
- Private capital raised
- $16.5M
- 2 Form D · last Apr 2021
- 66 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$12M
- Private capital raisedForm D · SEC · 1st filing$4.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Founders and team
Researcher links verified by same-company patents and grants- Maya SaidResearcherExecutive Officer, DirectorLinked by $400K in grants as PI
- Andrea JacksonDirectorNamed in SEC Form D filings
- David AucklandDirectorNamed in SEC Form D filings
- David FleshmanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 3- PendingProviding Personalized Health Care Information And Treatment RecommendationsUSPTOApplication 16711164
- PendingProviding Personalized Health Care Information And Treatment RecommendationsUSPTOApplication PCTUS2019065782
- PendingIntegrated Platform For Providing Personalized Health Care Information And Verified Social Network For PatientsUSPTOApplication 62778018
Recent research by its founders
- Abstract P5-10-20: Patient awareness of HER2-low in metastatic breast cancer: survey results in a patient-facing app20250 cites
- Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer20250 cites
- Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study)20236 cites
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .